Explore the vast range of titles available.

To estimate the global cost of establishing and operating the educational and refractive care facilities required to provide care to all individuals who currently have vision impairment resulting from uncorrected refractive error (URE). The global cost of correcting URE was estimated using data on the population, the prevalence of URE and the number of existing refractive care practitioners in individual countries, the cost of establishing and operating educational programmes for practitioners and the cost of establishing and operating refractive care facilities. The assumptions made ensured that costs were not underestimated and an upper limit to the costs was derived using the most expensive extreme for each assumption. There were an estimated 158 million cases of distance vision impairment and 544 million cases of near vision impairment caused by URE worldwide in 2007. Approximately 47 000 additional full-time functional clinical refractionists and 18 000 ophthalmic dispensers would be required to provide refractive care services for these individuals. The global cost of educating the additional personnel and of establishing, maintaining and operating the refractive care facilities needed was estimated to be around 20 000 million United States dollars (US$) and the upper-limit cost was US$ 28 000 million. The estimated loss in global gross domestic product due to distance vision impairment caused by URE was US$ 202 000 million annually. The cost of establishing and operating the educational and refractive care facilities required to deal with vision impairment resulting from URE was a small proportion of the global loss in productivity associated with that vision impairment.

To estimate the potential global economic productivity loss associated with the existing burden of visual impairment from uncorrected refractive error (URE). Conservative assumptions and national population, epidemiological and economic data were used to estimate the purchasing power parity-adjusted gross domestic product (PPP-adjusted GDP) loss for all individuals with impaired vision and blindness, and for individuals with normal sight who provide them with informal care. An estimated 158.1 million cases of visual impairment resulted from uncorrected or undercorrected refractive error in 2007; of these, 8.7 million were blind. We estimated the global economic productivity loss in international dollars (I$) associated with this burden at I$ 427.7 billion before, and I$ 268.8 billion after, adjustment for country-specific labour force participation and employment rates. With the same adjustment, but assuming no economic productivity for individuals aged > 50 years, we estimated the potential productivity loss at I$ 121.4 billion. Even under the most conservative assumptions, the total estimated productivity loss, in $I, associated with visual impairment from URE is approximately a thousand times greater than the global number of cases. The cost of scaling up existing refractive services to meet this burden is unknown, but if each affected individual were to be provided with appropriate eyeglasses for less than I$ 1000, a net economic gain may be attainable.

PurposeWe used systematic review and meta-analysis to identify and assimilate evidence quantifying blindness and visual impairment (VI) associated with myopic macular degeneration (MMD), then derived models to predict global patterns. The models were used to estimate the global prevalence of blindness and VI associated with MMD from 2000 to 2050.MethodsThe systematic review identified 17 papers with prevalence data for MMD VI fitting our inclusion criteria. Data from six papers with age-specific data were scaled to relative age-dependent risk and meta-analysed at VI and blindness levels. We analysed variance in all MMD VI and blindness data as a proportion of high myopia against variables from the place and year of data collection, with a model based on health expenditure providing the best correlation. We used this model to estimate the prevalence and number of people with MMD VI in each country in each decade.ResultsWe included data from 17 studies comprising 137 514 participants. We estimated 10.0 million people had VI from MMD in 2015 (prevalence 0.13%, 95% CI 5.5 to 23.7 million, 0.07% to 0.34%), 3.3 million of whom were blind (0.04%, 1.8 to 7.8 million, 0.03% to 0.10%). We estimate that by 2050, without changing current interventions, VI from MMD will grow to 55.7 million people (0.57%, 29.0 to 119.7 million, 0.33% to 1.11%), 18.5 million of whom will be blind (0.19%, 9.6 to 39.7 million, 0.11% to 0.37%).ConclusionThe burden of MMD blindness and VI will rise significantly without efforts to reduce the development and progression of myopia and improve the management of MMD.

Parabothusrotundifrons Voronina, Pruvost et Causse, 2016 was only known from the type locality, Saya de Malha Bank in the western Indian Ocean, described on the basis of six specimens. In February 2024, a total five specimens of this species (87.2–105.7 mm standard length) was procured from a multiday trawl bycatch at Veraval fishing harbour, Gujarat, northwestern coast of India. The report from Indian waters significantly extends the geographical range towards northeast and provides photographs of the fresh colouration. Also, the depth range of the species now extends from 130–250 m. A detailed morphological description, counts and radiographs are provided herein.

A new record of the Short–snouted scorpionfish, Scorpaenopsis obtusa Randall et Eschmeyer, 2002 is reported from India’s southeast coast. Three specimens were collected (67.6–75.1 mm SL ) as trawl-fishery bycatch at Tuticorin fishing harbour, India on 21 April 2022. Morphometric and meristic characters were measured and compared with published data. The record of this species from India expands the known distribution of S. obtusa , previously reported from Myanmar eastward. The above species is a new addition to the list of marine fishes of Indian coastal waters.

BackgroundInformed decisions on myopia management require an understanding of financial impact. We describe methodology for estimating lifetime myopia costs, with comparison across management options, using exemplars in Australia and China.MethodsWe demonstrate a process for modelling lifetime costs of traditional myopia management (TMM=full, single-vision correction) and active myopia management (AMM) options with clinically meaningful treatment efficacy. Evidence-based, location-specific and ethnicity-specific progression data determined the likelihood of all possible refractive outcomes. Myopia care costs were collected from published sources and key informants. Refractive and ocular health decisions were based on standard clinical protocols that responded to the speed of progression, level of myopia, and associated risks of pathology and vision impairment. We used the progressions, costs, protocols and risks to estimate and compare lifetime cost of myopia under each scenario and tested the effect of 0%, 3% and 5% annual discounting, where discounting adjusts future costs to 2020 value.ResultsLow-dose atropine, antimyopia spectacles, antimyopia multifocal soft contact lenses and orthokeratology met our AMM inclusion criteria. Lifetime cost for TMM with 3% discounting was US$7437 (CI US$4953 to US$10 740) in Australia and US$8006 (CI US$3026 to US$13 707) in China. The lowest lifetime cost options with 3% discounting were antimyopia spectacles (US$7280, CI US$5246 to US$9888) in Australia and low-dose atropine (US$4453, CI US$2136 to US$9115) in China.ConclusionsFinancial investment in AMM during childhood may be balanced or exceeded across a lifetime by reduced refractive progression, simpler lenses, and reduced risk of pathology and vision loss. Our methodology can be applied to estimate cost in comparable scenarios.

[web URL: http://www.who.int/entity/bulletin/volumes/93/10/15-156844/en/index.html]

This paper is the second part of the “Ichthyofauna of the Fresh and Brackish Waters of Russia and Adjacent Areas: Annotated List with Taxonomic Comments”, which we started in 2022 based on a critical analysis of scientific publications of the last 200 years, and on the data of the author’s research. The current paper includes all currently known fishes of the order Cypriniformes of Russia and adjacent waters, represented by three suborders Catostomoidei, Cobitoidei and Cyprinoidei, comprising ten families, 64 genera and 177 species. The most specious families were the Leuciscidae (59 species/33.3% of all species), Gobionidae (35/19.8%) and Xenocyprididae (23/13.0%), which together represent just over 66% the total cypriniform species. Fourteen of the studied species (24.7% of all cyprinids in Russia) are introduced species, 21 species (11.9%) are endemic; 32 species (18.1%) are recorded from Russia for the first time. In relation to the habitat, 131 species live and breed exclusively in fresh waters, 31 species are of freshwater origin, but can also tolerate slightly brackish waters, ten species are represented by anadromous forms (all with residential populations), and three species are amphidromic, capable of live and reproduce both in brackish water and in freshwater. According to the IUCN criteria, the majority of fish are classified as Least Concern (135 species/76.3%), but two species, Cobitis taurica and Gobio tauricus, are Critically Endangered.

This paper is the third part of the “Ichthyofauna of the Fresh and Brackish Waters of Russia and Adjacent Areas: Annotated List with Taxonomic Comments,” which we started in 2022, based on a critical analysis of scientific publications of the last 200 years, and on the data of the authors’ research. This current paper includes all currently known fishes of 8 orders from Siluriformes to Syngnathiformes of Russia and adjacent waters, represented by 18 families, 43 genera and 159 species.

Background/aimTo determine willingness to pay for children’s spectacles, and barriers to purchasing children’s spectacles in Cambodia.MethodsWe conducted vision screenings, and eye examinations as indicated, for all consenting children at 21 randomly selected secondary schools. We invited parents/guardians of children found to have refractive problems to complete a willingness to pay for spectacles survey, using a binary-with-follow-up technique.ResultsWe conducted vision screenings on 12 128 secondary schoolchildren, and willingness to pay for spectacles surveys with 491 parents/guardians (n=491) from Kandal and Phnom Penh provinces in Cambodia. We found 519 children with refractive error, 7 who had pre-existing spectacles and 14 recommended spectacles for lower ametropias. About half (53.2%; 95% CI 44.0% to 62.1%) of parents/guardians were willing to pay KHR70 000 (US$17.5; average market price) or more for spectacles. Mean willingness-to-pay price was KHR74 595 (US$18.6; 95% CI KHR64 505 to 86 262; 95% CI US$16.1 to US$21.6) in Phnom Penh and KHR55 651 (US$13.9; 95% CI KHR48 021 to 64 494; 95% CI US$12.0 to US$16.1) in Kandal province. Logistic regression suggested parents/guardians with college education (OR 6.8; p<0.001), higher household incomes (OR 8.0; p=0.006) and those wearing spectacles (OR 2.2; p=0.01) were more likely to be willing to pay ≥US$17.5. The most common reasons for being unwilling to pay US$17.5 were related to cost (58.8%). The most common barrier to spectacle wear was fear that spectacles weaken children’s eyes (36.0%).ConclusionsWith almost half of parents/guardians unwilling to pay for spectacles at the current average market price, financial support through a subsidised spectacle scheme might be required for children to access spectacles in Cambodia.